EIM
VNRX icon

Essex Investment Management’s VolitionRx Ltd VNRX Stock Holding History

Essex Investment Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-211
Closed -$6K – 431
2022
Q3 		$6K Hold
211
– – ﹤0.01% 391
2022
Q2 		$9K Buy
+211
New +$10.6K ﹤0.01% 389

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Essex Investment Management's VNRX Position: Q4 2022 in Review

Essex Investment Management sold out of VolitionRx Ltd (VNRX) in Q4 2022, closing a stake of 211 shares — an estimated $6K sold.

Essex Investment Management first reported a position in VNRX in Q2 2022 and held it in 2 quarters. The position peaked at $9K in Q2 2022. 34 funds tracked by Wall St. Rank hold VNRX as of Q4 2022.

  • Essex Investment Management reported no remaining VolitionRx Ltd position as of Q4 2022 after selling out during the quarter.
  • Essex Investment Management sold 211 VolitionRx Ltd shares in Q4 2022, an estimated $6K.
  • Essex Investment Management first reported a position in VolitionRx Ltd in Q2 2022 and held it in 2 quarters.
  • Essex Investment Management's VolitionRx Ltd position peaked at $9K in Q2 2022.
  • 34 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q4 2022.

Based on Essex Investment Management's 13F filing for Q4 2022, filed 3 Feb 2023.